Zafer Akman (@zaferakmanmd) 's Twitter Profile
Zafer Akman

@zaferakmanmd

Postdoctoral Associate @YaleIMed | Alumni @iu_cerrahpasa

ID: 1136601016097525760

linkhttps://medicine.yale.edu/profile/zafer-akman/ calendar_today06-06-2019 11:49:34

51 Tweet

347 Takipçi

375 Takip Edilen

Yale Nephrology (@yalenephrology) 's Twitter Profile Photo

Just out in JASN_News from Cantley lab: Preventing Adamts1 upregulation following loss of tubular Pkd1 effectively reduced cyst growth and preserved kidney function. 🔗👇 #PKD #ADPKD @ZfrAkmn Manga Motrapu, PhD Stefan Somlo Lloyd Cantley journals.lww.com/jasn/abstract/…

JASN_News (@jasn_news) 's Twitter Profile Photo

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by mutations in either the Pkd1 or Pkd2 genes leading to progressive cyst growth and often kidney failure. This study found that preventing Adamts1 upregulation following loss of tubular Pkd1 effectively

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by mutations in either the Pkd1 or Pkd2 genes leading to progressive cyst growth and often kidney failure. This study found that preventing Adamts1 upregulation following loss of tubular Pkd1 effectively
Zafer Akman (@zaferakmanmd) 's Twitter Profile Photo

Beyond grateful to continue my training at Yale alongside my partner! Thank you to our mentors and family for their unwavering support! This wouldn’t be possible without you! And thank you to Mark D. Siegel for the warm welcome to the Yale IM Traditional Residency Program family!

Beyond grateful to continue my training at Yale alongside my partner! Thank you to our mentors and family for their unwavering support! This wouldn’t be possible without you!

And thank you to <a href="/MarkDSiegel1/">Mark D. Siegel</a>  for the warm welcome to the <a href="/TradIMYale/">Yale IM Traditional Residency Program</a> family!
MrinalMkrishna (@mrinalmkrishna) 's Twitter Profile Photo

#TAVR vs #SAVR in low & intermediate risk population ⬇️ Death/stroke, bleeding, AF, AKI & patient-prosthesis mismatch ⬆️ Pacemaker implantation, reintervention, major vascular complications & paravalvular leak Thankful to Andrew M. Goldsweig, MD, MS & Michael Nanna sciencedirect.com/science/articl…

Eric Topol (@erictopol) 's Twitter Profile Photo

Another new possible benefit of GLP-1 drugs independent of any weight loss: Monoclonal Gammopathy of Undetermined Significance (MGUS, a pre-malignant blood disorder with known CV risk) reduction of CV events jamanetwork.com/journals/jaman…

Another new possible benefit of GLP-1 drugs independent of any weight loss: Monoclonal Gammopathy of Undetermined Significance (MGUS, a pre-malignant blood disorder with known CV risk) reduction of CV events
jamanetwork.com/journals/jaman…
Heartwise Research Group (@heartwiselab) 's Twitter Profile Photo

Our population is aging, and so must our science. 🧠🫀 HEARTWISE led by Michael Nanna and Abdulla A. Damluji, MD, PhD is now live, advancing cardiovascular research for a healthier, longer life. Explore the future of heart research: heartwiselab.com #HEARTWISE #AgingWell #CardioResearch

Michael Nanna (@michaelgnanna) 's Twitter Profile Photo

Excited to share HeartWise Lab a collaborative effort between myself and my friend Abdulla A. Damluji, MD, PhD focused on improving cardiovascular care and outcomes for older adults. heartwiselab.com

Heartwise Research Group (@heartwiselab) 's Twitter Profile Photo

We’re heading to #AHA25 in New Orleans! Our team will share new work on aging, prevention, and cardiovascular innovation through talks, posters, and panels. Excited to connect with colleagues pushing Cardiovascular health forward! Michael Nanna Abdulla A. Damluji, MD, PhD HeartWise Lab

We’re heading to #AHA25 in New Orleans!
Our team will share new work on aging, prevention, and cardiovascular innovation through talks, posters, and panels.
Excited to connect with colleagues pushing Cardiovascular health forward!
<a href="/MichaelGNanna/">Michael Nanna</a> <a href="/DrDamluji/">Abdulla A. Damluji, MD, PhD</a> <a href="/heartwiselab/">HeartWise Lab</a>
Yasser Jamil (@yasserjamil_md) 's Twitter Profile Photo

🚨 New in JACC Journals Advances. Our MA/SR explores outcomes of chronic total occlusion revascularization in studies that adequately represented older adults (≥75 y) Many thanks to my mentors Michael Nanna Abdulla A. Damluji, MD, PhD and team HeartWise Lab

🚨 New in <a href="/JACCJournals/">JACC Journals</a> Advances. Our MA/SR explores outcomes of chronic total occlusion revascularization in studies that adequately represented older adults (≥75 y) 

Many thanks to my mentors <a href="/MichaelGNanna/">Michael Nanna</a> <a href="/DrDamluji/">Abdulla A. Damluji, MD, PhD</a> and team <a href="/heartwiselab/">HeartWise Lab</a>
Zafer Akman (@zaferakmanmd) 's Twitter Profile Photo

Excited to have presented our work today at the AHA moderated poster session and grateful for the support from Michael Nanna and the entire HeartWise Lab team. Always great running into my co-residents and friends along the way. #AHA25 Yale Internal Medicine

Excited to have presented our work today at the AHA moderated poster session and grateful for the support from <a href="/MichaelGNanna/">Michael Nanna</a> and the entire <a href="/heartwiselab/">HeartWise Lab</a> team. Always great running into my co-residents and friends along the way. #AHA25 <a href="/YaleIMed/">Yale Internal Medicine</a>